EMN Add to watchlist $75.87 0.49 (-0.64%) Last updated: May 31, 2026 21:49
52-Week Range
$75.87
$56.11 $75.87 $83.47

Fundamentals Overview

Eastman Chemical Company is in the middle of its 52-week range with moderate valuation, trading relatively flat today.

Valuation moderate

P/E 21.9 P/B 1.44 P/S 1

Intrinsic value (DCF)

+21.3% upside vs price

Profitability

Net margin 4.6%

Risk (Beta)

1.06 — in line vol

Earnings & growth

EPS $3.47 Rev +10.3% Profit +1.9% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 58% confidence Risk: Moderate Volatility — Beta 1.06. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +21.3% upside vs price · Analyst grade: B+

Pressures (Sell):

Sentiment weakening (2 downgrades) · 3M vs S&P 500: -8.6%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$8.68B
P/E (TTM)
21.85
EPS (TTM)
$3.47
Dividend Yield
4.4%
52-Week Range
$56.11 - $83.47
Volume vs Avg
N/A
Beta
1.06

About

Eastman Chemical Company operates as a specialty materials company in the United States and internationally. The company's Additives & Functional Products segment offers hydrocarbon and rosin resins; organic acid-based solutions; amine derivative-based building blocks; metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators; specialty coalescent, specialty and commodity solvents, paint additives, and specialty polymers; heat transfer and aviation fluids; insolu...
Sector: Basic Materials
Headquarters: US
Employees: 14,000
IPO Date: Dec 1993
Beta: 1.06 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 13, Equal Weight: 2, Hold: 1, In Line: 2, Neutral: 2, Outperform: 2, Overweight: 6, Sector Perform: 2.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $92.01; current price is $75.87. That’s a +21.3% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 21.85
DCF value (model) $92.01 (21.3% upside)
PEG (TTM) N/A
P/B (TTM) 1.44
P/S (TTM) 1
P/FCF (TTM) 17.42
Liquidity & enterprise
Current Ratio (TTM) 1.47
Quick Ratio (TTM) 0.71
Cash Ratio (TTM) 0.24
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 4.62%
Gross margin (TTM) 19.77%
Operating margin (TTM) 9.35%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for EMN.

Analyst Sentiment at a Glance

B+ Sentiment Weakening
Buy 13Equal Weight 2Hold 1In Line 2Neutral 2Outperform 2Overweight 6Sector Perform 2
1 upgrade, 2 downgrades
Price Target Consensus
Current $75.87
Median $82.00
Consensus $79.89
Low consensus $70.00
High consensus $88.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
RBC Capital maintain Sector Perform Sector Perform 2026-05-05
Morgan Stanley maintain Overweight Overweight 2026-05-05
JP Morgan maintain Overweight Overweight 2026-05-04
Citigroup maintain Buy Buy 2026-05-04
Wells Fargo maintain Equal Weight Equal Weight 2026-05-04
Citigroup maintain Buy Buy 2026-04-16
JP Morgan upgrade Neutral Overweight 2026-04-14
UBS maintain Buy Buy 2026-04-09
Citigroup maintain Buy Buy 2026-03-12
Evercore ISI Group maintain In Line In Line 2026-02-18
Citigroup maintain Buy Buy 2026-02-03
Deutsche Bank maintain Hold Hold 2026-02-02
JP Morgan maintain Neutral Neutral 2026-02-02
B of A Securities maintain Buy Buy 2026-02-02
RBC Capital downgrade Outperform Sector Perform 2026-01-16
Citigroup maintain Buy Buy 2026-01-15
Keybanc maintain Overweight Overweight 2026-01-09
Wells Fargo downgrade Overweight Equal Weight 2025-12-19
Citigroup maintain Buy Buy 2025-12-18
Evercore ISI Group maintain In Line In Line 2025-11-11
Wells Fargo maintain Overweight Overweight 2025-11-05
UBS maintain Buy Buy 2025-11-05
UBS maintain Buy Buy 2025-11-01
B of A Securities maintain Buy Buy 2025-10-14
UBS maintain Buy Buy 2025-10-06
Mizuho maintain Outperform Outperform 2025-10-03
Citigroup maintain Buy Buy 2025-10-02
Wells Fargo maintain Overweight Overweight 2025-09-16
Goldman Sachs maintain Neutral Neutral 2025-08-07
RBC Capital maintain Outperform Outperform 2025-08-05